Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-07-31

FDA Approved: SAXAGLIPTIN — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for saxagliptin by Mylan Pharmaceuticals Inc., enabling a generic version of the diabetes medication for adults with type …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Saxagliptin (saxagliptin)

Snippet

ORIG AP for SAXAGLIPTIN (SAXAGLIPTIN)